Serum phenformin concentrations in patients with phenformin-associated lactic acidosis. 1977

L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein

Phenformin concentrations were measured in serum from seven patients with phenformin-associated lactic acidosis, and initial values ranging from 20 to 625 ng./ml. were obtained. Five of the seven patients had serum concentrations within the usual therapeutic range of up to 241 ng./ml. Serum phenformin concentrations were measured serially, and apparent half-lives of 5, 25, and 30 hours were obtained in three patients with serum creatinine concentrations of 1.7, 7.6, and 6.0 mg./dl., respectively. Although the half-life of phenformin was prolonged in azotemic patients, no correlation between serum creatinine concentration and serum phenformin could be demonstrated; furthermore, the severity of lactic acidosis as measured by arterial pH and lactate concentration did not correlate with the serum creatinine concentration.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic

Related Publications

L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
March 1985, The Journal of the Association of Physicians of India,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
July 1997, Annals of internal medicine,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
December 1996, Diabetes care,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
January 1978, Journal of dialysis,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
May 1975, American journal of hospital pharmacy,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
December 1974, Postgraduate medical journal,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
July 1972, California medicine,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
February 1974, The New Zealand medical journal,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
November 1984, The Journal of the Association of Physicians of India,
L A Conlay, and J H Karam, and S B Matin, and J E Loewenstein
November 1977, Annals of internal medicine,
Copied contents to your clipboard!